SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Huang YA)
 

Sökning: WFRF:(Huang YA) > A two‐center study ...

A two‐center study for the quality control of [18F]FDG using FASTlab phosphate cassettes

Huang, Ya-Yao (författare)
PET Center, Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan
Taylor, Stephen (författare)
Department of Nuclear Medicine, Royal Brisbane and Women’s Hospital, Herston, Australia
Koziorowski, Jacek (författare)
Linköpings universitet,Institutionen för medicin och hälsa,Medicinska fakulteten,Region Östergötland, Radiofysikavdelningen US
visa fler...
Chang, Yu-Ning (författare)
Molecular Imaging Center, National Taiwan University, Taipei, Taiwan
Kao, Wei-Hua (författare)
PET Center, Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan
Tzen, Kai-Yuan (författare)
PET Center, Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan; Molecular Imaging Center, National Taiwan University, Taipei, Taiwan
Shiue, Chyng-Yann (författare)
PET Center, Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan; Molecular Imaging Center, National Taiwan University, Taipei, Taiwan; PET Center, Department of Nuclear Medicine, Tri-Service General Hospital, Taipei, Taiwan
visa färre...
 (creator_code:org_t)
2016-06-17
2016
Engelska.
Ingår i: Annals of Nuclear Medicine. - : Springer. - 0914-7187 .- 1864-6433. ; 30:8, s. 563-571
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Objective: The GE FASTlab radiosynthesis module is routinely used for the production of [18F]FDG, utilizing the commercially available phosphate cassettes. Because of the observation of a white precipitate in the product vial before the product expiry time, we re-examined the quality of the produced [18F]FDG solution.Methods: Phosphate buffered [18F]FDG solution was synthesized on the FASTlab and analyzed at both National Taiwan University Hospital (NTUH) of Taiwan and Royal Brisbane and Women’s Hospital (RBWH) of Australia. In addition to the standard product quality control (QC), the concentration of aluminum (Al3+) as probable cause of the precipitations in the [18F]FDG solution was analyzed by inductively coupled plasma mass spectrometry (ICP-MS at RBWH) and inductively coupled plasma optical emission spectrometry (ICP-OES at NTUH), and using three semi-quantitative methods at NTUH, Advantec® Alumi Check Test Strip, Quantofix® Aluminum Test Strip and MColortest™ Aluminum Test kit.Results: The precipitates were observed in the [18F]FDG solution within 24 (NTUH) and 6 (RBWH) hours after the end of synthesis in 38–100 % of the batches, dependent on the batch of the FASTlab cassettes. Addition of metal-free HCl(aq) to aliquots of [18F]FDG containing precipitate, followed by ICP-MS analysis revealed Al3+ concentrations of 70–80 ppm. Al3+ concentrations of 10–12 ppm were detected in [18F]FDG batches that did not show any precipitation. In contrast, less than 5 ppm of the residual Al3+ was detected by semi-quantitative methods in all batches.Conclusion: The US (USP), British (BP), European (EP) and Japanese (JP) pharmacopeias demand that [18F]FDG for injection should be clear and particulate free within the given shelf-life/expiration time. To avoid Al-phosphate precipitation within the product expiry time, FASTlab citrate cassettes, rather than phosphate cassettes, should be used for [18F]FDG production. Although testing for Al3+ is not listed in the [18F]FDG monographs of the USP, BP and EP, residual Al3+ levels should be considered in the interests of patient safety.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)

Nyckelord

[18F]FDG
FASTlab
Phosphate
Cassette
Precipitate

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy